Analyst Ratings for Corcept Therapeutics (CORT)
CORT Rating Summary
CORT Price Target Summary
- Highest: $135.00 (Canaccord)
- Lowest: $50.00 (Truist Securities)
- Average: $88.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$88.00 (+21.1%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
Rating Score: 3.7 / 10
Percentile Rank: 35%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/13/2026 | UBS | Ashwani Verma | Upgrade | Neutral (N/A) |
72.00 (44.00) |
51.20 (72.65) |
41.89% | Details |
| 3/25/2026 | Wolfe Research | Kalpit Patel | Upgrade | Peerperform (Underperform) |
N/A (N/A) |
33.82 (72.65) |
114.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
